within Pharmacolibrary.Drugs.ATC.J;

model J01CG01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00021833333333333332,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.008199999999999999,
    k12             = 6.3,
    k21             = 6.3
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01CG01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Sulbactam is a beta-lactamase inhibitor used mainly in combination with beta-lactam antibiotics such as ampicillin to extend their spectrum of activity. It is primarily used to treat infections caused by beta-lactamase producing bacteria. Sulbactam is approved and in clinical use today, often as ampicillin/sulbactam.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers (n=12), both sexes, single-dose administration.</p><h4>References</h4><ol><li><p>O&#x27;Donnell, J, et al., &amp; Isaacs, R (2019). Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects. <i>Antimicrobial agents and chemotherapy</i> 63(9) –. DOI:<a href=\"https://doi.org/10.1128/AAC.00794-19\">10.1128/AAC.00794-19</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31307978/\">https://pubmed.ncbi.nlm.nih.gov/31307978</a></p></li><li><p>Sagan, O, et al., &amp; Srinivasan, S (2020). Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis. <i>Antimicrobial agents and chemotherapy</i> 64(3) –. DOI:<a href=\"https://doi.org/10.1128/AAC.01506-19\">10.1128/AAC.01506-19</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31843995/\">https://pubmed.ncbi.nlm.nih.gov/31843995</a></p></li><li><p>Schaad, UB, et al., &amp; Straehl, P (1986). Single-dose pharmacokinetics of intravenous sulbactam in pediatric patients. <i>Reviews of infectious diseases</i> 8 Suppl 5 S512–S517. DOI:<a href=\"https://doi.org/10.1093/clinids/8.supplement_5.s512\">10.1093/clinids/8.supplement_5.s512</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3025998/\">https://pubmed.ncbi.nlm.nih.gov/3025998</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01CG01;
